NCT07338305Active, not recruiting
Methotrexat to Hand Eczema in the BIOSKIN Cohort
The Copenhagen Translational Skin Immunology Biobank and Research Program - BIOSKIN: Methotrexat to Hand Eczema
Source: ClinicalTrials.gov · Last updated 13 Jan 2026
Brief summary (registry, in English)
Handeczema is a common chronic skin disease that markedly affect health and quality of life. Effective treatment is limited by the lack of biomarkers that can predict disease course, comorbidities and treatment response. This study is is an observational, prospective, study of patients initiating treatment with methotrexat at the Department of Dermatology and Allergy at Herlev- and Gentofte Hospital. The main aim is to study the clinical effect of methotrexat in patients with hand eczema. Secondary aims are to study drug survival, reasons for termination of treatment and side effects.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 27 Nov 2025
- Start date
- Nov 2025
- Primary completion date
- Sept 2026
- Lead sponsor
- Lone Skov
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07338305
What you commit to
- Study type: Observational
- Planned participants: 50
- From Nov 2025 to the primary completion date, Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any condition that, in the investigator's judgment, makes participation inappropriate or unsafe.
Other
- Inability or unwillingness to provide informed consent.
Who the study is looking for
- Individuals of any age with psoriasis, atopic dermatitis, contact dermatitis, or other inflammatory skin diseases.
- Patients seen at the Department of Dermatology and Allergy, Herlev and Gentofte Hospital, or recruited through public advertisement.
- Ability to provide informed consent (parent/guardian for minors).
- Healthy volunteers
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Dermatology and Allergy Coordinator of this site? Confirm its status | Hellerup | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.